A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic Castration-Resistant Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • VA West Los Angeles Medical Center - (CRS) - NAVREF - PPDS, Los Angeles, California, United States

  • UCSF, San Francisco, California, United States

  • Holden Comprehensive Cancer Center, Iowa City, Iowa, United States

  • Montefiore Einstein Cancer Center, The Bronx, New York, United States

  • Lifespan Cancer Institute, Providence, Rhode Island, United States

  • Carolina Urologic Research Center, Myrtle Beach, South Carolina, United States

  • Royal North Shore Hospital-Pacific Hwy, St Leonards, New South Wales, Australia

  • Sunshine Coast University Hospital, Birtinya, Queensland, Australia

  • Royal Brisbane & Womens Hospital, Herston, Queensland, Australia

  • Box Hill Hospital, Box Hill, Victoria, Australia

  • Irmandade Da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil

  • CEPHO - Centro de Estudos e Pesquisas em Hematologia e Oncologia, Santo André, São Paulo, Brazil

  • Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base - PPDS, São José do Rio Preto, São Paulo, Brazil

  • Instituto Do Câncer Do Estado de São Paulo Octávio Frias de Oliveira - ICESP, São Paulo, Brazil

  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada

  • Centre de recherche du Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada

  • Jewish General Hospital, Montreal, Quebec, Canada

  • EDOG - Institut Bergonie - PPDS, Bordeaux, Gironde, France

  • Centre Léon Bérard, Lyon, France

  • Institut Paoli Calmettes, Marseille, France

  • Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany

  • Studienpraxis Urologie, Nürtingen, Germany

  • Istituti Fisioterapici Ospitalieri, Rome, Lazio, Italy

  • Ospedale San Raffaele S.r.l. - PPDS, Milan, Lombardy, Italy

  • Seoul National University Bundang Hospital, Seongnam-si, Gyeonggido, South Korea

  • Seoul National University Hospital, Seoul, South Korea

  • Severance Hospital, Yonsei University Health System, Seoul, South Korea

  • Asan Medical Center., Seoul, South Korea

  • Samsung Medical Center, Seoul, South Korea

  • Hospital Universitario Cruces, Barakaldo, Vizcaya, Spain

  • C.H. Regional Reina Sofia - PPDS, Córdoba, Spain

  • Hospital Universitario 12 de Octubre, Madrid, Spain

  • Fundacion Instituto Valenciano de Oncologia (IVO), Valencia, Spain

  • Ankara Universitesi Tip Fakultesi Hastaneleri - Cebeci Hastanesi, Ankara, Turkey (Türkiye)

  • VM Medical Park Samsun Hastanesi, Atakum, Turkey (Türkiye)

  • Koc Universitesi Hastanesi, Istanbul, Turkey (Türkiye)

  • Izmir Medical Point Hospital, Izmir, Turkey (Türkiye)

  • Medical Park Seyhan Hospital, Seyhan, Turkey (Türkiye)

  • The Royal Marsden in Sutton, Surrey - Downs Rd, Sutton, Surrey, United Kingdom

Study leads
  • Clinical Trials

    Study Director

    Hoffmann-La Roche